A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients
Authors:
- François MeyerFMFrançois Meyer
- Michel GélinasMGMichel Gélinas
- André FortinAFAndré Fortin
- Abdenour NabidANAbdenour Nabid
- François BrochetFBFrançois Brochet
- Jean-Philippe MercierJMJean-Philippe Mercier
- Bernard TêtuBTBernard Têtu
- François HarelFHFrançois Harel
- Benoît MâsseBMBenoît Mâsse
- Éric VigneaultÉVÉric Vigneault
- Sylvie VassSVSylvie Vass
Open Access
- 5 April 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 97 (7) , 481-488
Abstract
Background: Although low dietary intakes of antioxidant vitamins and minerals have been associated with higher risks of cancer, results of trials testing antioxidant supplementation for cancer chemoprevention have been equivocal. We assessed whether supplementation with antioxidant vitamins could reduce the incidence of second primary cancers among patients with head and neck cancer. Methods: We conducted a multicenter, double-blind, placebo-controlled, randomized chemoprevention trial among 540 patients with stage I or II head and neck cancer treated by radiation therapy between October 1, 1994, and June 6, 2000. Supplementation with α-tocopherol (400 IU/day) and β-carotene (30 mg/day) or placebo began on the first day of radiation therapy and continued for 3 years after the end of radiation therapy. In the course of the trial, β-carotene supplementation was discontinued after 156 patients had enrolled because of ethical concerns. The remaining patients received α-tocopherol or placebo only. Survival was evaluated by Kaplan-Meier analysis. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). All statistical tests were two-sided. Results: After a median follow-up of 52 months, second primary cancers and recurrences of the first tumor were diagnosed in 113 and 119 participants, respectively. The effect of supplementation on the incidence of second primary cancers varied over time. Compared with patients receiving placebo, patients receiving α-tocopherol supplements had a higher rate of second primary cancers during the supplementation period (HR = 2.88, 95% CI = 1.56 to 5.31) but a lower rate after supplementation was discontinued (HR = 0.41, 95% CI = 0.16 to 1.03). Similarly, the rate of having a recurrence or second primary cancer was higher during (HR = 1.86, 95% CI = 1.27 to 2.72) but lower after (HR = 0.71, 95% CI = 0.33 to 1.53) supplementation with α-tocopherol. The proportion of participants free of second primary cancer overall after 8 years of follow-up was similar in both arms. Conclusions: α-Tocopherol supplementation produced unexpected adverse effects on the occurrence of second primary cancers and on cancer-free survival.Keywords
This publication has 22 references indexed in Scilit:
- The SU.VI.MAX StudyArchives of internal medicine (1960), 2004
- Incidence of Cancer and Mortality Following α-Tocopherol and β-Carotene SupplementationJAMA, 2003
- Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Prévention des seconds cancers primaires par supplémentation vitaminique chez les patients traités pour un cancer ORLBulletin du Cancer/Radiothérapie, 1996
- The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male SmokersNew England Journal of Medicine, 1994
- Nutrition Intervention Trials in Linxian, China: Supplementation With Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-Specific Mortality in the General PopulationJNCI: Journal of the National Cancer Institute, 1993
- Vegetables, fruit, and cancer. I. EpidemiologyCancer Causes & Control, 1991
- Multiple Malignancies of the Lung and Head and NeckArchives of Surgery, 1986
- Simultaneous determination of plasma retinol, α-tocopherol, lycopene, α-carotene, and β-carotene by high-performance liquid chromatographyAnalytical Biochemistry, 1984